Page 313 - IJB-8-4
P. 313

Gu, et al.
           2.   Zou L, Lai H, Zhou Q, et al., 2011, Lasting Controversy on   15.  Knowlton S, Tasoglu S, 2016, A Bioprinted Liver-on-a-chip for
               Ranibizumab and Bevacizumab. Theranostics, 1:395–402.   Drug Screening Applications. Trends Biotechnol, 34:681–2.
               https://doi.org/10.7150/thno/v01p0395               https://doi.org/10.1016/j.tibtech.2016.05.014
           3.   Hurwitz  H,  Fehrenbacher  L,  Novotny  W,  et al., 2004   16.  Phan DT, Wang X, Craver BM, et al., 2017, A Vascularized
               Bevacizumab Plus Irinotecan, Fluorouracil, and Leucovorin   and Perfused Organ-on-a-chip Platform for Large-scale Drug
               for Metastatic Colorectal Cancer. N Engl J Med, 350:2335–42.  Screening Applications. Lab Chip, 17:511–20.
               https://doi.org/10.1056/NEJMoa032691            17.  Chramiec  A,  Teles  D,  Yeager  K,  et  al.,  2020,  Integrated
           4.   Santoro MM, 2014, Antiangiogenic Cancer Drug using the   Human Organ-on-a-chip  Model for Predictive  Studies of
               Zebrafish Model. Atertisclero Thromb Vasc Biol, 34:1846–53.  Anti-tumor  Drug  Efficacy  and  Cardiac  Safety.  Lab Chip,
               https://doi.org/10.1161/ATVBAHA.114.303221          20:4357–72.
           5.   Beedie SL, Diamond AJ, Fraga LR, et al., 2017, Vertebrate      https://doi.org/10.1039/d0lc00424c
               Embryos as Tools for Anti-angiogenic Drug Screening and   18.  Yang Q, Lian  Q, Xu F, 2017, Perspective:  Fabrication  of
               Function. Reprod Toxicol, 70:49–59.                 Integrated Organ-on-a-chip Via Bioprinting. Biomicrofluidics,
               https://doi.org/10.1016/j.reprotox.2016.11.013      11:031301.
           6.   Kim S, Ko J, Lee SR,  et al.,  2021, Anchor-IMPACT:      https://doi.org/10.1063/1.4982945
               A  Standardized  Microfluidic  Platform  for  High-throughput   19.  Lee GY, Kenny PA, Lee EH, et al., 2007, Three-dimensional
               Antiangiogenic  Drug Screening.  Biotechnol  Bioeng,   Culture Models of Normal and Malignant Breast Epithelial
               118:2524–35.                                        Cells. Nat Methods, 4:359–65.
           7.   Van Duinen V, Stam W, Mulder E, et al., 2020, Robust and      https://doi.org/10.1038/nmeth1015
               Scalable Angiogenesis Assay of Perfused 3D Human iPSC-  20.  Wang L, Tao T, Su W, et al., 2017, A Disease Model of Diabetic
               derived Endothelium for Anti-angiogenic Drug Screening. Int   Nephropathy  in  a  Glomerulus-on-a-chip  Microdevice.  Lab
               J Mol Sci, 21:4804.                                 Chip, 17:1749–60.
               https://doi.org/10.3390/ijms21134804                https://doi.org/10.1039/c7lc00134g
           8.   Nie J, Gao Q, Wang Y, et al., 2018, Vessel-on-a-chip with   21.  Sharifi  F,  Yesil-Celiktas  O,  Kazan  A,  et al.,  2020, A
               Hydrogel-based Microfluidics. Small, 14:e1802368.   Hepatocellular  Carcinoma Bone Metastasis-on-a-chip
               https://doi.org/10.1002/smll.201802368              Model  for Studying  Thymoquinone-loaded  Anticancer
           9.   Huh D, Matthews BD, Mammoto  A,  et  al., 2010,    Nanoparticles. Biodes Manuf, 3:189–202.
               Reconstituting  Organ-level  Lung Functions on a Chip.   22.  Liu Y, Yang Q, Zhang H, et al., 2021, Construction of Cancer-
               Science, 328:1662–8.                                on-a-chip for Drug Screening. Drug Discov Today, 26:1875–
               https://doi.org/10.1126/science.1188302             90.
           10.  Zhang B, Korolj A, Lai BF, et al., 2018, Advances in Organ-     https://doi.org/10.1016/j.drudis.2021.03.006
               on-a-chip Engineering. Nat Rev Mater, 3:257–78.  23.  Tavakol  DN,  Fleischer  S,  Vunjak-Novakovic  G,  2021,
           11.  Pampaloni  F, Reynaud  EG, Stelzer  EH, 2007,  The  Third   Harnessing Organs-on-a-chip to Model Tissue Regeneration.
               Dimension Bridges the Gap between Cell Culture and Live   Cell Stem Cell, 28:993–1015.
               Tissue. Nat Rev Mol Cell Biol, 8:839–45.            https://doi.org/10.1016/j.stem.2021.05.008
               https://doi.org/10.1038/nrm2236                 24.  Zhao Y, Rafatian N, Feric NT, et al., 2019, A Platform for
           12.  Sun  W, Luo Z, Lee  J,  et al., 2019, Organ-on-a-chip  for   Generation of Chamber-specific Cardiac Tissues and Disease
               Cancer and Immune Organs Modeling. Adv Healthc Mater,   Modeling. Cell, 176:913–27.e18.
               8:1801363.                                          https://doi.org/10.1016/j.cell.2018.11.042
               https://doi.org/10.1002/adhm.201801363          25.  Zubizarreta  ME, Xiao S, 2020, Bioengineering  Models of
           13.  Huang D, Liu T, Liao J, et al., 2021, Reversed-Engineered   Female Reproduction. Bi Des Manuf, 3:237–51.
               Human Alveolar Lung-on-a-chip Model. Proc Nat Acad Sci      https://doi.org/10.1007/s42242-020-00082-8
               U S A, 118:e2016146118.                         26.  Caballero  D, Blackburn  SM, De Pablo  M,  et  al., 2017,
               https://doi.org/10.1073/pnas.2016146118             Tumour-vessel-on-a-chip Models for Drug  Delivery.  Lab
           14.  Yang Q, Xiao Z, Lv X, et al., 2021, Fabrication and Biomedical   Chip, 17:3760–71.
               Applications of Heart-on-a-chip. Int J Bioprint, 7:370.  27.  Gu Z, Fu J, Lin H, et al., 2020, Development of 3D Bioprinting:
               https://doi.org/10.18063/ijb.v7i3.370               From Printing Methods to Biomedical Applications. Asian J

                                       International Journal of Bioprinting (2022)–Volume 8, Issue 4       305
   308   309   310   311   312   313   314   315   316   317   318